| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer¢s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 775 | 2019 |
| Tau and Aâ imaging, CSF measures, and cognition in Alzheimer¢s disease MR Brier, B Gordon, K Friedrichsen, J McCarthy, A Stern, J Christensen, ... Science translational medicine 8 (338), 338ra66-338ra66, 2016 | 758 | 2016 |
| High-precision plasma â-amyloid 42/40 predicts current and future brain amyloidosis SE Schindler, JG Bollinger, V Ovod, KG Mawuenyega, Y Li, BA Gordon, ... Neurology 93 (17), e1647-e1659, 2019 | 699 | 2019 |
| Tau kinetics in neurons and the human central nervous system C Sato, NR Barthélemy, KG Mawuenyega, BW Patterson, BA Gordon, ... Neuron 97 (6), 1284-1298. e7, 2018 | 557 | 2018 |
| Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 530 | 2018 |
| Span, CRUNCH, and beyond: working memory capacity and the aging brain NJ Schneider-Garces, BA Gordon, CR Brumback-Peltz, E Shin, Y Lee, ... Journal of cognitive neuroscience 22 (4), 655-669, 2010 | 470 | 2010 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer¢s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 459 | 2020 |
| Neuroanatomical correlates of aging, cardiopulmonary fitness level, and education BA Gordon, EI Rykhlevskaia, CR Brumback, Y Lee, S Elavsky, ... Psychophysiology 45 (5), 825-838, 2008 | 331 | 2008 |
| Assessment of racial disparities in biomarkers for Alzheimer disease JC Morris, SE Schindler, LM McCue, KL Moulder, TLS Benzinger, ... JAMA neurology 76 (3), 264-273, 2019 | 284 | 2019 |
| Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease AJ Aschenbrenner, BA Gordon, TLS Benzinger, JC Morris, JJ Hassenstab Neurology 91 (9), e859-e866, 2018 | 270 | 2018 |
| Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease E McDade, G Wang, BA Gordon, J Hassenstab, TLS Benzinger, V Buckles, ... Neurology 91 (14), e1295-e1306, 2018 | 263 | 2018 |
| A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer¢s disease S Salloway, M Farlow, E McDade, DB Clifford, G Wang, JJ Llibre-Guerra, ... Nature medicine 27 (7), 1187-1196, 2021 | 252 | 2021 |
| Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World … P Lewczuk, P Riederer, SE O¢bryant, MM Verbeek, B Dubois, PJ Visser, ... The world journal of biological psychiatry 19 (4), 244-328, 2018 | 252 | 2018 |
| Neurovascular coupling in normal aging: a combined optical, ERP and fMRI study M Fabiani, BA Gordon, EL Maclin, MA Pearson, CR Brumback-Peltz, ... Neuroimage 85, 592-607, 2014 | 230 | 2014 |
| Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging SE Schindler, JD Gray, BA Gordon, C Xiong, R Batrla-Utermann, M Quan, ... Alzheimer's & Dementia 14 (11), 1460-1469, 2018 | 229 | 2018 |
| The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging BA Gordon, K Friedrichsen, M Brier, T Blazey, Y Su, J Christensen, ... Brain 139 (8), 2249-2260, 2016 | 196 | 2016 |
| Effects of measurement method, wavelength, and source-detector distance on the fast optical signal G Gratton, CR Brumback, BA Gordon, MA Pearson, KA Low, M Fabiani Neuroimage 32 (4), 1576-1590, 2006 | 164 | 2006 |
| Tau PET in autosomal dominant Alzheimer¢s disease: relationship with cognition, dementia and other biomarkers BA Gordon, TM Blazey, J Christensen, A Dincer, S Flores, S Keefe, ... Brain 142 (4), 1063-1076, 2019 | 154 | 2019 |
| AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure S Mishra, BA Gordon, Y Su, J Christensen, K Friedrichsen, K Jackson, ... Neuroimage 161, 171-178, 2017 | 147 | 2017 |
| Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE å4 genotype S Mishra, TM Blazey, DM Holtzman, C Cruchaga, Y Su, JC Morris, ... Brain 141 (6), 1828-1839, 2018 | 132 | 2018 |
Tammie L.S. Benzinger, MD, PhDProfessor of Radiology and Neurosurgery, Washington University School of Medicine in Saint LouisVerified email at wustl.edu
